Clinical Trial Update: Use of Dexmedetomidine to Reduce Emergence Delirium Incident in Children [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating dexmedetomidine to reduce emergence delirium in children has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Agitation
• Anesthesia
• Pediatrics

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: St. Luke's-Roosevelt Hospital Center | Conditions: Agitation, Anesthesia | Phase 3 | Status: COMPLETED | Results posted: 2018-11-27